We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Stockal+Disclaimer.pdf
11 own
26 watching
Current Price
$38.64
$-1.41
(-3.52%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,944.09M
52-Week High
67.66000
52-Week Low
35.62000
Average Volume
0.16M
Dividend Yield
--
P/E Ratio
95.1793
Market Capitalization2,944.09M52-Week High67.6600052-Week Low35.62000Average Volume0.16MDividend Yield--P/E Ratio95.1793What does the Stockal+Disclaimer.pdf do?
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable, inhalation, and intranasal products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company's product portfolio comprises enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treatment of deep vein thrombosis; naloxone for treating opioid overdose; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection for the dispersion and absorption of other injected drugs; and lidocaine jelly, a local anesthetic product for urological procedures. It also provides lidocaine topical solution for various procedures; phytonadione injection for newborn babies; syringe products, which include critical care drugs, such as morphine, atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; lorazepam injection for surgery and medical procedures; ketorolac for acute pain management; and procainamide for documented ventricular arrhythmias. In addition, the company manufactures and distributes recombinant human insulin and porcine insulin. Further, it develops Primatene Mist, an over-the-counter epinephrine inhalation product candidate that is intended to be used for the temporary relief of mild symptoms of intermittent asthma. Additionally, the company has a pipeline of 20 generic and proprietary product candidates in various stages of development for various indications. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. The company was established in 1996 and is headquartered in Rancho Cucamonga, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
10 months ago
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Get Rating) EVP Rong Zhou sold 5,000 shares of the companys stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $51.79, for a total value of $258,950.00. Following the transaction, the ...
Zolmax
10 months ago
Amphastar Pharmaceuticals (NASDAQ:AMPH Get Rating) and Crinetics Pharmaceuticals (NASDAQ:CRNX Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, ...
Ticker Report
11 months ago
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Get Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,440,000 shares, an increase of 9.9% from the March 31st total of 1,310,000 shares. Approximately 4...
Accesswire
12 months ago
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 24, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will provide a Business update and hold a Conference call today, Monday, April 24, 2023, at 6:00 am Pacific Time.To access the conference call, please dial 877-407-0989, or...
Zolmax
1 year ago
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH Get Rating) from a buy rating to a strong-buy rating in a research report report published on Tuesday . Amphastar Pharmaceuticals Stock Down 0.2 % AMPH stock opened at $35.36 on Tuesday. The firm has a 50-day moving average ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
Can Indians buy Stockal+Disclaimer.pdf shares?
How can I buy Stockal+Disclaimer.pdf shares from India?
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
What is today’s traded volume of Stockal+Disclaimer.pdf?
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
Current Price
$38.64
$-1.41
(-3.52%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.